跳至主要内容
临床试验/NCT01886079
NCT01886079Unknown4 期

The Effects of Dexmedetomidine on Postoperative Renal Function in Valvular Heart Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
200
试验地点
1
主要终点
Comparison of postoperative renal function in patients with or without dexmedetomidine undergoing valvular heart surgery:

研究概览

简要总结

The purpose of study is to compare the incidence of acute kidney injury in patients receiving perioperative dexmedetomidine or placebo undergoing valvular heart surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients over the age of 20 scheduled for valvular heart surgery

排除标准

  • Left ventricular-ejection fraction < 30%
  • Preexisting congestive heart failure
  • Severe coronary artery disease
  • Hemodynamically unstable arrhythmia
  • Cardiogenic shock during perioperative period
  • Ventricular assist device
  • Severe renal dysfunction (eGFR < 15ml/min per 1.73m2)

研究组 & 干预措施

Dexmedetomidine group

Experimental

干预措施: dexmedetomidine (Drug)

Saline group

Placebo Comparator

干预措施: Saline (Drug)

结局指标

主要结局

Comparison of postoperative renal function in patients with or without dexmedetomidine undergoing valvular heart surgery:

时间窗: 24 hours after surgery.

BUN/Creatinine, cystatin C, eGFR, urine output Incidence of acute kidney injury (based on the AKIN criteria)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验